“…Thirteen trials reported neurochemical outcomes, that is, trophic factors, 8,34,38,49,56,63,72,73,77 oxidative stress, 35,43,49,63,64 and/or inflammatory markers, 34,38,49,72,73,77 with most not reporting medication status when outcomes were taken. Ten trials reported neuroimaging outcomes, that is, brain functional activation, 53,54,56,69,70,75 connectivity, 48,57,58,65,68,78 structure, 48,60 or volume 48,60 measured through fMRI or functional near-infrared spectroscopy in 1 trial, 69 mostly “on” medication 54,56-58,60,65,69,70,75 ; and dopamine receptor binding 7,53 measured “off” medication through positron emitted tomography. Neuroimaging trials examined different brain networks and used different imaging techniques and analysis methods.…”